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Nitric oxide (NO) is a gaseous diatomic radical that is involved in a wide range of physiological and patholog-
ical functions in biology. Conceptually, the biochemistry of NO can be separated into three stages: generation
(stage 1), translocation (stage 2), and action (stage 3). In stage 1 the oxygenase domain of NO synthase
converts L-arginine to L-citrulline and NO (g). Owing to its short-lived nature, this molecule is converted
into a different nitrogen oxide such as NO2, an organonitrosyl such as a nitrosothiol, or a metal nitrosyl
such as a heme-nitrosyl, for transportation in stage 2. Each of these derivatives features unique physical
characteristics, chemical reactivity, and biological activity. Upon delivery in stage 3, NO exerts its physiolog-
ical or pathological function by reaction with biomolecules containing redox-active metals or other residues.Introduction
Historically, nitric oxide (NO) was known as an industrial and
automotive pollutant that was highly toxic and environmentally
damaging (Culotta and Koshland, 1992). The photochemical
reaction of NO with ozone causes O3 to break down into dioxy-
gen and leads to depletion of the ozone layer. Additionally, atmo-
spheric NO can be converted to nitric acid and has been
implicated in acid rain. For these reasons one of the primary
functions of catalytic converters in automobiles is to reduce
the amount of NO released into the atmosphere. Although this
diatomic molecule is formed as an intermediate in the Ostwald
process, whereby ammonia is oxidized to nitric acid, it has
almost no practical value in industry (Sadykov et al., 2000).
Recently, NO has been utilized in the fabrication of semiconduc-
tors, and the number of patents concerning these processes has
increased dramatically (Yun et al., 2007).
By the end of the 1980s, the uniformly negative perception of
NO had begun to change as research in various fields, including
immunology, oncology, and cardiology, began to divulge diverse
physiological roles for the molecule. Interest in NO grew rapidly,
and in 1992 it was named ‘‘Molecule of the Year’’ (Culotta and
Koshland, 1992). Subsequently, the Nobel Prize in Physiology
or Medicine was awarded for the identification of NO as a sig-
naling molecule in the cardiovascular system (Furchgott, 1999;
Ignarro, 1999; Murad, 1999). The known functions of NO in
biology continue to grow and now range from neuroprotection
and the immune response to protein regulation and chemother-
apeutic resistance (Bonavida and Baritaki, 2011; Bronte and
Zanovello, 2005; Calabrese et al., 2007; Carreau et al., 2011;
Heo, 2011; Keswani et al., 2011; Turchi, 2006).
The diverse identities and activities of NO in vivo can be under-
stood by considering three distinct stages in its lifetime, namely,
generation, translocation, and action (Figure 1), most of which
involve metal ions. During the first stage, NO is generated by ni-
tric oxide synthase (NOS), an enzyme that converts L-arginine
into NO (g) at an iron-porphyrin, or heme, center. Next, NO (g)Chemistry & Biologeither diffuses directly to its target, or it is converted to: (1) a
different oxide of nitrogen, such as NO2 or N2O3; (2) an organo-
nitrosyl (E-NO) compound, where E is a sulfur-, nitrogen-, or
carbon-containing moiety; or (3) a metal-nitrosyl (M-NO)
complex. Some of these species are better suited for delivery
of NO and others for longer-term storage. Finally, NO or a deriv-
ative thereof can exert its physiological or pathophysiological
functions by interaction with: (1) redox-active metals; (2) redox-
active metals bound to or in the vicinity of redox-active ligands;
(3) redox-inactive metals supported by redox-active ligands,
such as zinc finger proteins; or (4) metal-free organic species
including peptides containing cysteine, tryptophan, and/or
tyrosine.
Stage 1—Generation by NOS
Investigation of the mechanism by which NO is generated in
living systems requires detailed kinetic studies of the various
isoforms of NOS or, as a minimum alternative, their oxygenase
domains. Small-molecule biomimetic complexes of metalloen-
zyme active sites typically do not reproduce the second- and
third-coordination spheres provided by the protein architecture,
which can supply hydrogen-bonding or redox-active amino acid
side-chain interactions necessary for proper enzyme function. In
this section we describe the structure of NOS and address
possible mechanisms by which the enzyme could generate NO
from L-arginine. Ultimately, elucidation of the mechanism will
require more extensive use of genetic, biochemical, and bio-
analytical techniques.
Structure
NOSs are enzymes that effect the synthesis of mammalian NO
from L-arginine in a dioxygen- and NADPH-dependent manner
(Vallance and Leiper, 2002). During one complete catalytic cycle,
a molecule of L-arginine and twomolecules of dioxygen are con-
verted to one molecule of NO, one molecule of L-citrulline, and
twomolecules of H2O in a process that requires three exogenous
electrons and protons. Crystallographic studies have revealedy 18, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1211
Figure 1. Stages of NO in Biology
Generation of NO from L-arginine is performed byNOS (stage 1). Translocation
of NO itself or its derivatives, such as other nitrogen oxides (NOx), organo-
nitrosyls (E-NO), or metal-nitrosyl complexes (M-NO), involves transport of NO
from where it is generated to where it is required (stage 2). Actions of NO in
biology are mediated by its reactivity with biomolecules containing redox-
active metals, redox-active ligands, or other metal-free species (stage 3).
Figure 2. Domain Structure and Components of NOS
The oxygenase domain (red) contains a heme active site and tetrahy-
drobiopterin cofactor, as well as cysteine residues that bind zinc (green) to
form the active dimer. The reductase domain (blue) contains flavin mono-
nucleotide, flavin adenine dinucleotide, and nicotinamide adenine dinucleotide
cofactors that supply the oxygenase domain with electrons. Calmodulin
(purple) is also involved in activating NOS, but the sensitivity of enzyme
function to calcium concentrations varies among the different isoforms.
Figure 3. Oxygenase Domain of a Canonical NOS
Heme units (red), NHA (purple), tetrahydrobiopterin (blue), and cysteine resi-
dues (orange) that bind zinc(II) to afford the active dimer (PDB ID: 3HSO).
Molecular models were rendered with PyMOL (http://www.pymol.org).
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analogous to that found in cytochrome P450, with tetrahydro-
biopterin in close proximity to the heme active site as well as a
reductase domain farther away (see Figure 2 for all NOS compo-
nents and Figure 3 for the oxygenase domain) (Li et al., 2006).
Mechanism
The conversion of L-arginine into NO and L-citrulline occurs in
two discrete mechanistic steps (Figure 4). First, L-arginine is
hydroxylated to form N-hydroxy-L-arginine (NHA), which is
then converted to L-citrulline with concomitant release of NO.
Current understanding of this cycle invokes an [FeIV = O(por+)]
intermediate, similar to that observed in cytochrome P450, as
the species that hydroxylates L-arginine (Li et al., 2007).
However, recent experiments cast some doubt on this assign-
ment because iodosylbenzene-generated ferryl NOS does not
result in conversion of L-arginine to NHA (Zhu and Silverman,
2008). Therefore, an alternative mechanism for this step has
been proposed, whereby an iron(III) peroxo species forms that
deprotonates a guanidinium nitrogen atom in L-arginine. The
lone pair on the neutral imine can then effect nucleophilic attack
at the terminal, or distal, oxygen atom in the iron(III) hydroperoxo
unit, leading to formation of NHA. During the second step the
same iron(III) peroxo unit attacks the imine carbon atom of
NHA, and subsequent collapse of this intermediate releases
NO and L-citrulline (Li et al., 2007; Woodward et al., 2010).
Recently, detailed studies of this NOS-catalyzed process by
mutagenesis, substrate/product analysis, and magnetic reso-
nance methods (EPR and ENDOR), suggest that both ferric per-
oxo and ferryl intermediates can be generated during a typical
catalytic cycle (Woodward et al., 2009). Each intermediate might
effect different steps, with L-arginine conversion to NHA catal-
ysis promoted by the ferric peroxo species and NHA decompo-
sition to L-citrulline by a ferryl (Davydov et al., 2009).1212 Chemistry & Biology 18, October 28, 2011 ª2011 Elsevier Ltd AModel Complexes
Although no complexes that mimic both the coordination envi-
ronment and reactivity of NOS yet exist, several notable approx-
imations have been prepared over the past 10 years. One of
the simplest examples is the ruthenium complex I, which can
catalyze the transformation of arginine to citrulline in the pres-
ence of H2O2, with concomitant generation of NO (Figure 5A)
(Marmion et al., 2001). However, given the structure of the
NOS active site, there is greater interest in heme-type mimics.
The fluorinated heme complex [Fe(TPPF20)] (IIa, TPPF20 = tetra-
kis(pentafluorophenyl)porphyrin) catalyzes the H2O2-driven
oxidation of NHA to citrulline and the nitrile, forming NO in the
process (Figure 5B) (Keser}u et al., 2000). Similarly, reaction of
[Fe(TMP)] (IIb, TMP = tetra(mesityl)porphyrin) with fluorenone
oxime in the presence of O2 affords NO (trapped by the heme)
and fluorenone, analogous in this context to citrulline (Figure 5C)
(Wang et al., 1999).ll rights reserved
Figure 4. Working Hypothesis for the Generation
of NO by NOS
L-arginine is oxidized to N-hydroxy-arginine, accompa-
nied by the consumption of two protons and one electron.
This intermediate is then converted to L-citrulline, with
concomitant generation of NO, in a process that requires
two additional electrons and one proton.
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There are three isoforms of the homodimeric NOS enzyme in
mammals—endothelial, neuronal, and inducible—that share
roughly 50% sequence homology (Vallance and Leiper, 2002).
The first two, endothelial NOS (eNOS) and neuronal NOS
(nNOS), are constitutive, whereas the last, inducible NOS
(iNOS), is inducible, typically by an immune response. The indi-
vidual monomers do not display any NOS activity but form the
active homodimeric enzyme when linked by a {Zn(Cys)4} unit in
which two cysteine ligands are supplied by each monomer
unit. Calmodulin binding to eNOS and nNOS is required for enzy-
matic activity, and its affinity for the enzyme may or may not
depend on Ca2+ concentration (Roman et al., 2002). In contrast
the binding of calmodulin to iNOS, also necessary for enzyme
function, is calcium independent, and thus, the NOS activity of
this isoform is independent of [Ca2+].
eNOS is an important part of the cardiovascular system, and is
essential for vasodilation and the maintenance of a healthy
cardiovascular state (Vallance and Leiper, 2002). Chemical inhi-
bition or knockdown of eNOS causes vasoconstriction, hyper-
tension, and severe aneurisms in some instances. This isoform
is also responsible for the regulation of vascular-endothelial
growth factor and, thus, plays a role in angiogenesis.
Despite the name, nNOS can be found in nerve endings aswell
as muscles (Vallance and Leiper, 2002). Outside of the brain,
nNOS modulates processes ranging from bladder relaxation to
respiration. Mice in which this enzyme has been genetically
deleted exhibit impaired balance and night vision. Although
nNOS has been implicated in long-term potentiation, these
knockout mice are still capable of normal learning and memory
tasks. A multitude of physiological functions are performed by
the neuronal isoform under normal conditions, such as neuro-
genesis, whereas pathologies such as ischemic brain damage
and Parkinson’s disease can also arise when the enzyme mal-
functions (Zhou and Zhu, 2009).
iNOS functions in an immunoprotective capacity, serving to
fight off infection from sources ranging from bacteria to virusesChemistry & Biology 18, October 28,(Vallance and Leiper, 2002). This isoform is not
expressed in healthy somatic cells but can be
rapidly transcribed in response to disease.
Unlike the other isoforms, iNOS can produce
large concentrations of NO in a short period of
time.
Bacterial NOS (bNOS) is analogous to the
mammalian enzyme and has a similar heme
oxygenase domain (Gusarov et al., 2008). This
enzyme is required for normal Gram-positive
bacterial growth, successful infection of a target,
and defense against oxidant-based immune
response. One notable difference betweenbNOS and the mammalian isoforms is that the former lacks an
integrated reductase domain as an integral part of the enzyme.
Bacteria expressing this enzyme can produceNOwithout a dedi-
cated reductase by recruiting one from the host. Presumably,
such behavior could serve as a foundation for the development
of a new class of antibiotics against bNOS enzymes in patho-
genic bacteria, such as those associated with anthrax, sepsis,
and other infectious diseases (Kim et al., 2007, 2008; Shatalin
et al., 2008).
Recently, substantial evidence has accumulated that
suggests the existence of an entirely separate isoform of NOS
localized within mitochondria (mtNOS) (Finocchietto et al.,
2009). However, this hypothesis has been the subject of contro-
versy, the prevailing contrary argument stipulating that mtNOS is
merely a localized variant of one of the three major isoforms
(Lacza et al., 2006).
Stage 2—Translocation and Storage
After synthesis, NO must diffuse or be transported away from
NOS to exert its effects. Recent studies have suggested that
the lifetime of NO in aerobic, biological milieu could be too short
to account for its observed functions (Liu et al., 1998; Thomas
et al., 2001). Other oxides of nitrogen (Figure 6), S-nitrosothiols,
and metal-nitrosyl complexes might serve as storage vessels or
delivery vehicles that retain NO until needed or transport it to
sites where it is required. S-Nitrosothiols and metal-nitrosyl
complexes can release NO by thermal decomposition, metal-
catalyzed processes, or illumination. Because translocation of
NO in vivo involves the movement of NO (g) or one of its deriva-
tives, investigations into this behavior under physiological and
pathophysiological conditions require tools for the detection of
NO (g) or related species. To address this need, we have devised
sensors for the turn-on fluorescent detection of NO (g) selectively
over other potentially interfering species (Lim and Lippard, 2007;
McQuade et al., 2010; Pluth et al., 2011). Enormous progress has
been achieved with ‘‘indirect’’ NO probes, which detect nitrogen
oxides derived from NO (g) (Nagano and Yoshimura, 2002; Yang2011 ª2011 Elsevier Ltd All rights reserved 1213
Figure 5. Model Complexes that Exhibit
NOS-Type Reactivity
Generation of NO has been achieved from (A)
arginine using a ruthenium-EDTA complex and
H2O2, (B) NHA using a fluorinated iron-porphyrin
complex and H2O2, and (C) fluorenone oxime
using an iron-tetra(mesityl)porphyrin complex
and O2.
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(g) under various healthy or disease states will nonetheless
require a sensor that is selective for NO (g). A sensor that is not
selective for NO (g) may afford a false-positive response, incor-
rectly reporting HNO, ONOO, or other reactive nitrogen species
(RNS) derived from NO, thus obfuscating the relationship
between NO (g) generation and the physiology or pathophysi-
ology being studied. Similarly, investigations into the biological
effects of other RNS, such as HNO, require sensors that are
selective for HNO over NO (g) and other derivatives. Such
constructs have recently been reported (Rosenthal and Lippard,
2010; Tennyson et al., 2007; Zhou et al., 2011).
Nitrogen Oxides
As a consequence of its generation from NOS in vivo, NO is
formed in the presence of O2 and water. From this environment
and the redox-active nature of the molecule, NO can be con-
verted to a variety of nitrogen oxide (NOx) species, with formal
N-atom oxidation states ranging from +1 to +5.
Nitroxyl, N(1+). Nitroxyl (HNO) may play an important role in
biology, with a signaling pathway possibly orthogonal to that
for NO (Fukuto et al., 2005; Miranda, 2005). Studies to elucidate
the separate roles of these molecules have been hampered by
a lack of spectroscopic tools that can distinguish the two. To
address this limitation, our lab has pursued bioimaging agents
selective for HNO over NO and other RNS, and we have recently
succeeded in preparing fluorescent sensors for the selective1214 Chemistry & Biology 18, October 28, 2011 ª2011 Elsevier Ltd All rights reserveddetection of HNO in aqueous solution
(Rosenthal and Lippard, 2010; Tennyson
et al., 2007; Zhou et al., 2011). Although
HNO is toxic at high concentrations,
causing severe depletion of cellular gluta-
thione, HNO can play a beneficial role in
the cardiovascular system, where it inter-
acts with targets that do not react directly
with NO (Fukuto et al., 2005; Miranda,
2005). One possible source of HNO
in vivo is from reaction of an S-nitrosothiol
with another thiol to afford a disulfide
and HNO. Although one-electron reduc-
tion of NO followed by protonation
would afford HNO, this process is spin
forbidden (Shafirovich and Lymar, 2002).
The lowest-energy configuration for NO
is the triplet state, but for HNO it is the
singlet state. Realization of this spin
change led to revision of the pKa value
for HNO from 3.4 to 11.4. However, coor-
dination to a transition metal could favor
the singlet state for NO, and metal-
bound HNOs have been previously reported to exhibit much
lower pKa values (7) (Southern et al., 2001). The free triatomic
HNOmolecule can react with thiols to form disulfide and hydrox-
ylamine, whereby HNOmay function as a one-electron reductant
or a hydrogen-atom source (Fukuto et al., 2005).
NO, N(2+). Although NO is a product of the NOS catalytic cycle,
this diatomic radical is unstable in aerobic, aqueous solutions,
especially in the presence of redox-activemetal ions and organic
compounds (Nagano andYoshimura, 2002). Under physiological
conditions, the half-life for NO can range from minutes to milli-
seconds. Early studies suggested that the intravascular concen-
trations of NOmight be too low to account for its observed vaso-
dilative behavior because of its limited diffusion range and
stability in a hemoglobin-rich environment (Liu et al., 2007).
More recent findings have revealed a more complicated picture,
where factors such as the local environment and oxygen
concentration can significantly affect NO diffusion (Liu et al.,
2010). As a result, consideration must be given to various
nitrogen oxides and other NO-derived species that can be
formed from NO.
Nitrite (NO2
), N(3+). Simple autooxidation of NO in aerobic,
aqueous solution will give rise to NO2
, but not nitrate (NO3
)
(Lewis and Deen, 1994). Reduction of NO3
 to NO2
 is effected
by bacteria inhabiting humans, where studies of the NO2
 anion
have revealed it to have important biological effects and even
serve as an indicator of infection (Lundberg et al., 2004, 2008).
Figure 6. Redox Relationship between NOx Species as a Function of
Nitrogen Oxidation State
Numbers on the slopes correspond to the potentials (DE0
0) required to effect
that change in oxidation state. Adapted from Koppenol et al. (1992).
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NO2
 could serve as an alternative to NOS for NO production
in some cardiovascular and gastroesophageal tissues (Asanuma
et al., 2007; Zweier et al., 2010). Although the majority of NO3

in humans is excreted in the urine, the absence of bacteria
therein precludes any formation of NO2
 (Carlsson et al.,
2001). However, during bacterial infection of the urinary system,
NO2
production occurs, and its presence can be used as a diag-
nostic indicator of such infection. Acidification of nitrite-enriched
urine below pH 5.5 is lethal to all known urinary infectious
bacteria, and both modern treatments and folk remedies for
bacterial urinary infections employ deliberate acidification via
dietary habits, such as cranberries and citrus. Because the phys-
iological and bactericidal functions of NO2
 are dependent on
acidic conditions, the relevant intermediate is believed to be
HNO2, which disproportionates to the presumed active species
N2O3 and water. NO2
 can also be reduced by deoxyhemoglo-
bin or xanthine oxidoreductase to afford NO and hydroxide
ion. Conversely, reaction of NO2
 with oxyhemoglobin results
in the formation of NO3
.
Peroxynitrite (ONOO), N(3+). ONOO is formed in vivo by the
diffusion-limited reaction between NO and superoxide (Koppe-
nol et al., 1992). This anion is highly oxidizing and can even effect
tyrosine nitration, resulting in a variety of pathophysiological
effects ranging from inflammation to cancer (Salvemini et al.,
2006). Additionally, ONOO can cause oxidation of cysteine to
cystine or sulfone formation from methionine (Ullrich and Kiss-
ner, 2006). When ONOO is combined with two molecules of
NO, N2O3 and NO2
 are formed.
Nitrogen Dioxide (NO2/N2O4) N(4+). NO2/N2O4 is an unstable
species in aqueous solution and will readily behave as a one-
electron oxidant to generate NO2
 (Hughes, 2008). Dimerization
of NO2 to N2O4 affords a species best viewed as [NO
+][NO3
],
and subsequent hydration affords NO2
 and NO3
 (Addison,
1980). Because N2O4 formally contains an NO
+ unit, it can
act as a nitrosating agent in the generation of organonitrosyl
compounds.
Dinitrogen Trioxide (N2O3), N(4+) and N(2+). N2O3 can be formed
by the disproportionation of nitrous acid or by radical coupling of
NO with NO2 (Lundberg et al., 2004, 2008). This species is too
unstable in aqueous solution to exert any direct influence butChemistry & Biologcan deliver both NO+ and NO. In the former capacity, N2O3 func-
tions as a nitrosating agent and enables the formation of species
such as S-nitrosothiols and N-nitrosamines with concomitant
formation of NO2
. In the latter capacity, N2O3 serves as a source
of NO and NO2. A commonly proposed mechanism for the
response of ‘‘indirect’’ NO (g) probes involves reaction with
N2O3 derived from the aerobic oxidation of NO (Nagano and
Yoshimura, 2002; Yang et al., 2010).
NO3
, N(5+). NO3
 contains a nitrogen atom in its highest
possible oxidation state (5+). It has long been considered to be
an inert, thermodynamic sink for RNS (Lundberg et al., 2004,
2008). The bulk of NO3
 in humans (60%–80%) is supplied by
vegetable consumption. The remainder is produced by isomeri-
zation of ONOO or in the reaction of NO with oxygenated heme
proteins. Because humans lack enzymes for which NO3
 is
a substrate, the majority of NO3
 (60%) is excreted in the urine
unaltered. Interestingly, nearly 25% of plasma NO3
 is directed
to the salivary glands and incorporated into saliva at concentra-
tions 10-fold greater than those found in plasma. This observa-
tion is significant given the fact that there are a number of
bacteria inhabiting the human mouth and gastrointestinal
system. Whereas NO3
 is an inert compound for humans,
bacteria employ NO3
 reductases in the conversion of NO3
 to
NO2
. These bacteria can process the NO3
 in saliva or else-
where into NO2
. Although NO3
 has been associated with
cancer and other diseases, as well as with beneficial NO-derived
gastric bactericidal functions, its ‘‘effects’’ are due to the action
of NO2
 or other downstream RNS. For example ingestion of
NO3
 caused a large increase in plasma NO2
 in test subjects,
but if they did not swallow, no such increase was noted (Lund-
berg and Govoni, 2004). Other studies have shown that NO3

has a protective effect in the gastrointestinal system, such as
the prevention of stress-induced injury in rats, accompanied by
an increased generation of NO (Miyoshi et al., 2003). However,
treatment of the rats’ oral cavities with topical antibiotics caused
death of the resident bacteria and abolished the protective effect
of the dietary NO3
. Presumably, bacteria in the mouth reduce
NO3
 to NO2
, which then migrates to the stomach, where the
acidic environment can cause formation of a number of RNS
through nitrous acid as an intermediate.
Organonitrosyls
Because N2O3 can function as a nitrosating agent, it is believed
to be the intermediate by which nitrosamines and nitrosothiols
are formed. Reaction of morpholine or glutathione with NO under
aerobic conditions resulted in the formation ofN-nitrosomorpho-
line and S-nitrosoglutathione, respectively (Keshive et al., 1996).
By comparison, the same reaction performed under anaerobic
conditions afforded no change. Kinetic analysis of this reaction
at neutral pH indicated that the responsible intermediate was
N2O3.
S-Nitrosothiols are commonplace in vivo, and there is
evidence that these molecules are the predominant carriers of
NO, but the mechanism of ‘‘NO’’ delivery by these species is
disputed (Al-Sa’doni and Ferro, 2005; Tannenbaum and White,
2006; Tsikas and Fro¨lich, 2004). Some evidence suggests that
heterolysis of RS-NO directly transfers a nitrosonium (NO+) frag-
ment to the target in a process termed nitrosation. Other exper-
iments indicate that homolysis of the S-N bond liberates 0.5
equivalents of disulfide (RSSR) and 1 equivalent of NO, whichy 18, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1215
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latter pathway is too slow for practical signaling purposes unless
accelerated by a transition metal or other redox-active agent to
facilitate homolytic decomposition of the RSNO (Bazylinski and
Hollocher, 1985). Most S-nitrosothiols decay with first-order
kinetics under thermal conditions (Field et al., 1978) and with
second-order kinetics when catalyzed by metals (Stamler and
Toone, 2002).
N-Nitrosamines can function as alkylating agents and are
therefore potent carcinogens (Georgiadis et al., 1991; Hebels
et al., 2010). However, these RNS can also exhibit antibacterial
effects by a similar mechanism. Although the details for the bio-
logical activity of this class of compounds are unclear, loss of
dinitrogen occurs, thus excluding possible involvement by
derived RNS. Alternatively, nitrosamines can lead to the forma-
tion of reactive oxygen species (Garcı´a et al., 2009), which are
themselves potent biological effectors of physiology (Forman
et al., 2010) and pathophysiology (Wang, 2008).
Metal-Nitrosyl Complexes
Iron complexes bearing nitrosyl and thiolate ligands have been
encountered in biology. They exhibit a range of functions from
NO donation to antitumor activity (Butler and Megson, 2002).
One intriguing feature of these {Fe-S-NO} complexes is their
ability to release NO under photolytic conditions (Ford, 2008).
Roussin’s black salt [Fe4S3(NO)7]
 (RBS) has been used in vaso-
dilation studies (Butler and Megson, 2002). Roussin’s red salt
[Fe2S2(NO)4]
2– (RRS) has been studied as a photolabile source
of NO for the sensitization of cancer cells to radiotherapy (Bour-
assa et al., 1997). Roussin’s red esters [Fe2(NO)4(m-SR)2] (RREs)
are attractive substrates for NO photodelivery studies, given
the precedence for alkylation of the bridging sulfides in RRS
to enhance solubility. However, the reverse reaction of NO
photodelivery is NO recapture, and this process occurs rapidly
(109 M1 s1). Adaptation of this scaffold to incorporate longer
wavelength or multiphoton chromophores within the R groups
affords RREs with better photophysical properties and quantum
yields, improvements beneficial for clinical applications (Ford,
2008).
Mononitrosyl iron complexes (MNICs) supported by thiolate
ligands have only been detailed recently (Harrop et al., 2006,
2007).MeasurementsofNOtransfer fromMNICsrevealedaquan-
titative process that was complete within 30 min of photoirradia-
tion (Ford, 2008). AlthoughMNICs have yet to be observed unam-
biguously in biology, EPR spectra consistent with MNICs have
been obtained from the nitrosylation of mammalian ferritin (Lee
et al., 1994). Intriguingly, the properties of small-molecule MNICs
suggest that these complexes could exert possibly orthogonal
influences to those of dinitrosyl iron compounds (DNICs) or other
{Fe-S-NO} complexes. For example MNICs could function as
rapidly releasing donors of NO in vivo, whereas DNICs would
behave as stores of NO. Thus, chemical modification of the {Fe-
S-NO}storagecomplexes toaffordMNICswould facilitate release
of NO. Previous studies of other {Fe-S-NO} complexes have
shown that photoinduced NO release occurs, but the quantum
yields are poor, and back reactions are very rapid (Ford, 2008).
Stage 3—Targets and Action
Whatever the means of NO transport and storage, it exerts its
effects through reactions with biomolecules. Given the radical1216 Chemistry & Biology 18, October 28, 2011 ª2011 Elsevier Ltd Acharacter of NO, it can react with a wide variety of redox-active
species, including targets composed of: (1) redox-active metals,
(2) redox-active metals bound to or in the vicinity of redox-active
ligands, (3) redox-inactive metals supported by redox-active
ligands, or (4) metal-free organic species. For example NO can
inactivate mitochondrial aconitase by disrupting its [4Fe-4S]
active site cluster through formation of a DNIC (vide infra). Simi-
larly, NO binds tightly to cobalamin and inhibits the activity of
methionine synthase. These results suggest regulatory roles for
NO in energy production and C1 metabolism, processes that
are essential for life. To gain a better understanding of the mech-
anisms by which NO can exert its influence in reactions with
biomolecules, we have initiated a program to investigate the
fundamental NO chemistry of transition metal thiolate com-
plexes. The results for NO reactions with iron-, cobalt-, and
nickel-thiolate coordination complexes have been recently re-
ported (Harrop et al., 2006, 2007, 2008; Tennyson et al., 2008;
Tonzetich et al., 2009, 2010). In this section we present a few
illustrative examples of the reactivity of NO with biomolecules
and the functions that this chemistry affects. No attempt
has been made to be comprehensive or to cover all classes of
reactions.
Complexes with Redox-Active Metals
Soluble Guanylyl Cyclase. One of the first targets identified for
NO in biology was soluble guanylyl cyclase (sGC), an enzyme
that features an NO-sensing and a catalytic cyclase domain. In
the reduced state the active site of the NO-sensing domain con-
tains a ferrous heme coordinated by two axial histidine ligands
(Spiro, 2008). Crystallographic analysis of the inactive, ferric
enzyme revealed that the pyrrole moieties within the heme unit
were significantly distorted from the expected coplanar geom-
etry. Reaction with NO by a reductive nitrosylation mechanism
afforded an Fe(II) center with attendant flattening of the heme
ring. Because a number of protein residues are within close
proximity to this heme unit and potentially cause the steric
distortion, the geometric change therein induces a significant
displacement of the N-terminal helices and loops. Accompa-
nying the heme flattening is the displacement of one of the
coordinated histidine residues, a process that correlates with
activation of the catalytic cyclase domain. Upon activation,
sGC catalyzes the transformation of guanosine triphosphate to
cyclic guanosine monophosphate (Gilles-Gonzalez and Gonza-
lez, 2005; Krumenacker et al., 2004), an effector for awide variety
of signal transduction events. Included are phototransduction,
vascular smooth muscle modulation, electrolytic homeostasis,
as well as the activation of protein kinases, ion channels, and
phosphodiesterases.
To gain greater insight into the underlying chemical process by
which the NO-heme interaction affords enzymatic activity, a
number of fundamental studies have been performed. Reaction
of CO with ferrous sGC caused displacement of one of the histi-
dine ligands but did not induce activity (Burstyn et al., 1995).
Reconstitution of this enzyme with nonnative metals allowed
further investigation of the dependence of enzymatic activity
on the coordination environment of the heme unit, i.e., five-
versus six-coordinate (Dierks et al., 1997). Upon reaction of
the manganese analog of sGC with NO, a six-coordinate metal
nitrosyl was formed, and the enzyme lacked activity. However,
treatment of the cobalt-reconstituted sGC with NO yielded all rights reserved
Chemistry & Biology
Reviewfive-coordinate cobalt-nitrosyl porphyrinoid complex, and the
enzyme was active. Activation of the ferrous [Fe(por)(His)2]
enzyme by NO proceeds by formation of the five-coordinate
ferrous mononitrosyl [Fe(por)(NO)] (Zhao et al., 1999). Other
nitrogen oxides, such as NO2
, also interact with these heme-
based systems in a physiologically meaningful manner (Ford,
2010).
Cytochrome P450. This enzyme is responsible for the oxidative
metabolism and degradation of a variety of physiological
substrates and potential toxins. In the resting state the active
site comprises ferric heme bound by a cysteine ligand at the
proximal axial site. Treatment of cytochrome P450 with an NO
donor caused a decrease in testosterone hydroxylation activity,
which could be reversed upon addition of dithiothreitol (Mina-
miyama et al., 1997). Analysis of the NO-inhibited enzyme by
EPR spectroscopy revealed a 1:1:1 hyperfine-structured line at
g = 2.0, consistent with formation of an {Fe-NO}7 complex.
However, irreversible suppression of activity was also observed
and attributed to conversion of the axial cysteine to S-nitroso-
cysteine. Recent studies of NO coordination to different
cytochrome P450 enzymes from Mycobacterium tuberculosis
revealed multiple, distinct kinetic processes, suggesting that
NO may regulate such events within the same organism (Ouellet
et al., 2009).
The reactivity of cytochrome P450 with NO has been modeled
with the biomimetic iron complex [Fe(TPPM)] (TPPM = 5,10,15-
tris(o-pivalamidophenyl)-20-(o-{2-mercaptomethylphenoxy}-aceta-
midophenyl)porphyrin) (Franke et al., 2005). Addition of 14NO (g)
to the ferric-heme complex followed by EPR spectral analysis
revealed a signal at g = 2.02 with three-line hyperfine coupling.
Using 15NO (g) afforded a similar spectrum, albeit with a two-
line coupling pattern associated with the signal at g = 2.02.
This heme-nitrosyl-thiolate can undergo subsequent reaction
with excess NO to afford a complex featuring heme-nitrosyl
and nitrosocysteine components.
Iron-Sulfur Clusters. Mitochondrial aconitase contains a [4Fe-4S]
cluster in the active state that is reduced to a [3Fe-4S] configu-
ration with nearly identical structural parameters upon inactiva-
tion (Robbins and Stout, 1989). Treatment of the EPR-silent
enzyme with NO affords an inactive protein with an EPR spec-
trum consistent with formation of a [3Fe-4S] cluster and a
DNIC (Asanuma et al., 2007; Duan et al., 2009; Kennedy et al.,
1997). Similar reactivity is observed with the [4Fe-4S] cluster in
the active site of dihydroxyacid dehydratase (Duan et al.,
2009). In a similar manner, addition of NO to the redox-active
transcription factor SoxR, composed of a [2Fe-2S] cluster in its
active site, induces activation via DNIC formation (Ding and
Demple, 2000).
Ribonucleotide Reductase. This enzyme is responsible for
conversion of ribonucleotides to deoxyribonucleotides. Binding
of NO to the enzyme was studied as a surrogate for dioxygen
binding, and two {Fe-NO}7 units were observed (Haskin et al.,
1995). Reaction of this enzyme with NO inhibits activity by
quenching a stable tyrosine radical at the active site. However,
adventitious reduction of two molecules of NO yields a diiron(III)
state without generating the tyrosyl radical.
This type of binding and reduction also occurs with NO reduc-
tases (Kurtz, 2007). Although the mechanism is unresolved, two
steps that must be involved are iron-nitrosyl bond formation andChemistry & Biolognitrogen-nitrogen bond formation. For example the latter could
occur on one iron bearing two nitrosyl ligands or between two
separate {Fe-NO}7 units. Related work on the binding of CO to
this enzyme suggested that two separate {Fe-CO} units form
that interact with one another, implying that a similar configura-
tion could be involved in the nitrogen-nitrogen bond-forming
step with NO (Lu et al., 2004).
Cobalamin. The cobalt(II) unit in this cofactor is essential for
methionine synthesis and C1 metabolism; treatment of cells
with NO donors disrupts these functions (Danishpajooh et al.,
2001). Although lacking a cobalt(II)-thiolate bond, cobalamin
binds NO very rapidly and tightly (Wolak et al., 2001).
Complexes with Redox-Inactive Metals
Zinc Finger Proteins. Zinc finger domains are encoded by 3%–
10% of the human genome (Andreini et al., 2006; Blasie and
Berg, 2002) and are frequently employed in the recognition of
specific sequences within DNA, RNA, and proteins (Dhanase-
karan et al., 2006; Gamsjaeger et al., 2007; Lunde et al., 2007).
NO can disrupt DNA binding of nuclear zinc finger proteins,
and this loss of function may result from cysteine nitrosation
followed by zinc release (Berendji et al., 1999; Garba´n et al.,
2005; Kro¨ncke and Carlberg, 2000).
The action of NO on zinc thiolate complexes can regulate NOS
activity. At the dimer interface of the enzyme is a {Zn(Cys)4}
2
unit, with two residues supplied by each monomer (Raman
et al., 1998). Introduction of an NO donor under aerobic condi-
tions produces S-nitrosation at these key residues, displace-
ment of zinc, and subsequent loss of enzymatic activity (Mitchell
et al., 2005). Replacement of the exogenous NO donor with an
activator of iNOS activity also afforded an S-nitrosated enzyme.
Variants of the enzyme in which amonomer is missing one or two
of the key cysteine residues have much lower basal activity and
aremore sensitive to NO donors. Under aerobic, aqueous condi-
tions, NO is converted to N2O3, which can then nitrosate the
cysteine residues in the bridging {Zn(Cys)4}
2 unit.
Metallothioneins (MTs). These enzymes contain multiple zinc
cysteine units and are involved in maintaining cellular zinc
homeostasis. Addition of S-nitrosothiols to MTs caused labiliza-
tion of zinc, presumably by cysteine nitrosation (Chen et al.,
2002). This observation suggests a role for NO in the regulation
of zinc homeostasis.
Conclusions
From its early recognition as an industrial pollutant and toxic gas,
NO has become one of the most actively researched signaling
and regulatory molecules in living systems. The three isoforms
of NOS have been implicated in processes ranging from vasodi-
lation to the immune response, but the precise details of the
mechanism of NO synthesis remain unknown. Furthermore, the
belief that NO can freely diffuse over long distances has come
under scrutiny, and there is growing evidence that other nitrogen
oxides, organonitrosyls, and metal-nitrosyl complexes are im-
portant in the transportation and storage of NO. Delivery of NO
at the target can induce effects ranging from activation of gene
transcription to suppression of enzyme function. The funda-
mental chemistry of NO in vivo and the biochemical processes
that it mediates depend on whether the target contains a com-
plex of a redox-active metal and redox-active ligands, a com-
plex composed of a redox-active metal only, a complex of ay 18, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1217
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Reviewredox-inactive metal supported by redox-active ligands, or
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